Do we know how much is acquisition (Topos) and legal cost for the company, otherwise results looks to OK for me. Cash on hand is about $29.6M so I reckon this will last probably 4-5 months with number of staffs NUX have. I do anticipate a CR soon if price starts to move up.
- Forums
- ASX - By Stock
- NXL
- Ann: FY23 Preliminary Results Update
Ann: FY23 Preliminary Results Update, page-6
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.38 |
Change
-0.120(3.43%) |
Mkt cap ! $1.096B |
Open | High | Low | Value | Volume |
$3.47 | $3.52 | $3.37 | $2.710M | 790.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 776 | $3.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.19 | 142 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 776 | 3.650 |
1 | 2623 | 3.620 |
5 | 7789 | 3.550 |
5 | 3057 | 3.540 |
9 | 2235 | 3.510 |
Price($) | Vol. | No. |
---|---|---|
3.200 | 5210 | 1 |
3.210 | 187 | 1 |
3.220 | 2162 | 1 |
3.230 | 1188 | 1 |
3.300 | 79 | 1 |
Last trade - 15.59pm 15/07/2024 (20 minute delay) ? |
Featured News
NXL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online